Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Allow: |
Title | MobiDox Health Technologies, |
Description | Our Home Our Approach Our Solutions Company About Team Contact Automate and Optimize Drug Safety Management MobiDox Health Technologies, Inc is striving to he |
Keywords | N/A |
WebSite | mobidox.co |
Host IP | 192.169.221.188 |
Location | United States |
Site | Rank |
US$1,911
Last updated: 2023-05-13 04:23:44
mobidox.co has Semrush global rank of 0. mobidox.co has an estimated worth of US$ 1,911, based on its estimated Ads revenue. mobidox.co receives approximately 220 unique visitors each day. Its web server is located in United States, with IP address 192.169.221.188. According to SiteAdvisor, mobidox.co is safe to visit. |
Purchase/Sale Value | US$1,911 |
Daily Ads Revenue | US$1 |
Monthly Ads Revenue | US$52 |
Yearly Ads Revenue | US$635 |
Daily Unique Visitors | 14 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
mobidox.co. | A | 599 | IP: 192.169.221.188 |
mobidox.co. | NS | 3600 | NS Record: ns74.domaincontrol.com. |
mobidox.co. | NS | 3600 | NS Record: ns73.domaincontrol.com. |
mobidox.co. | MX | 3600 | MX Record: 20 alt2.aspmx.l.google.com. |
mobidox.co. | MX | 3600 | MX Record: 10 aspmx.l.google.com. |
mobidox.co. | MX | 3600 | MX Record: 30 aspmx2.googlemail.com. |
mobidox.co. | MX | 3600 | MX Record: 30 aspmx3.googlemail.com. |
mobidox.co. | MX | 3600 | MX Record: 20 alt1.aspmx.l.google.com. |
mobidox.co. | TXT | 3600 | TXT Record: google-site-verification=xUGBC5Qufm0sKmCwp8gWf-I7ij6q0UIRMfe18kzhrXw |
mobidox.co. | TXT | 3600 | TXT Record: v=spf1 include:_spf.google.com ~all |
Home Our Approach Our Solutions Company About Team Contact Automate and Optimize Drug Safety Management MobiDox Health Technologies, Inc is striving to help pharmaceutical companies and pharmacovigilance organizations process drug safety data. Our Approach Pre-market clinical trials evaluate the safety and efficacy of a new drug. Post-market pharmacovigilance activities uncover additional adverse events not seen during clinical trials or those that occur at a higher rate. Identifying additional safety and efficacy data is a requirement of pharmaceutical companies and drug regulatory agencies. Adverse event case processing is the most labor intensive task of Drug Safety professionals. To help address this issue we are developing a drug safety management platform with an automated workflow solution. Faster case processing. More compliant regulatory submissions. Stronger safety profile of drug. Our Solutions Pharmacovigilance Workflow Automation We have developed a web based platform to |